Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
US9101564B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9101564-B2 |
| Application number | US-201013261236-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 29, 2010 |
| Priority date | Sep 30, 2009 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A heparanase activity inhibitor containing, as an active ingredient, a 4-alkylresorcinol represented by formula (I): wherein R represents a C1-6 linear or branched alkyl group.
Opening claim text (preview).
The invention claimed is: 1. A method for suppressing formation of wrinkles caused by a reduced level of heparan sulfate in an epidermal basal membrane, comprising administering, to a subject in need thereof, an effective amount of 4-isobutylresorcinol as an active ingredient. 2. A method for inhibiting heparanase activity, comprising administering, to a subject in need thereof, 4-isobutylresorcinol as an active ingredient. 3. The method acco…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.